UPENN — Philadelphia, Pennsylvania

UPENN is a clinical research site located in Philadelphia, Pennsylvania, United States 19104-2648.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

UPENN has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Autism Spectrum Disorder, Neurodevelopmental Disorders, Solid Tumor.

Sponsors: Health Resources and Services Administration (HRSA), Gilead Sciences, Abramson Cancer Center at Penn Medicine.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPENN?

UPENN has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPENN conducted?

UPENN has 6 clinical trials on record, with 2 currently active. Their work covers Autism Spectrum Disorder, Neurodevelopmental Disorders, Solid Tumor.

Is UPENN accredited by Crixeo Health?

Yes — UPENN holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UPENN?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.